ERYTECH Selects Triple Negative Breast Cancer as Next Indication for Eryaspase

February 13, 2018

Set-up activities for Phase 2 clinical study ongoing and patient enrollment expected to start Q3 2018 LYON, France--(BUSINESS WIRE)--Feb. 13, 2018-- Regulatory News: ERYTECH Pharma (Euronext: ERYP- Nasdaq: ERYP), a clinical-stage

Read More

Erytech Pharma: Monthly Information Related to Total Number of Voting Rights and Shares Composing the Share Capital – January 31, 2018

February 12, 2018

Article 223-16 of general regulation of French Autorité des Marchés Financiers LYON, France--(BUSINESS WIRE)--Feb. 12, 2018-- Regulatory News: Erytech Pharma (Euronext: ERYP- Nasdaq: ERYP): Listing markets: Euronext Paris

Read More